4lmq
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
- | The entry 4lmq is ON HOLD | + | The entry 4lmq is ON HOLD until Paper Publication |
- | Authors: Zhong, Z., Wang, J., Li, B., Xiang, H., Ultsch, M., Coons, M., Wong, T | + | Authors: Zhong, Z., Wang, J., Li, B., Xiang, H., Ultsch, M., Coons, M., Wong, T, Chiang, N.Y., Clark, S., Clark, R., Quintana, L., Gribling, P., Suto, E., Barck, K., Corpuz, R., Yao, J., Takkar, R., Lee, W.P., Damico-Beyer, L.A., Carano, R.D., Adams, C., Kelley, R.F., Wang, W., Ferrara, N. |
Description: Development and Preclinical Characterization of a Humanized Antibody Targeting CXCL12 | Description: Development and Preclinical Characterization of a Humanized Antibody Targeting CXCL12 |
Revision as of 20:12, 7 August 2013
Unreleased structure
The entry 4lmq is ON HOLD until Paper Publication
Authors: Zhong, Z., Wang, J., Li, B., Xiang, H., Ultsch, M., Coons, M., Wong, T, Chiang, N.Y., Clark, S., Clark, R., Quintana, L., Gribling, P., Suto, E., Barck, K., Corpuz, R., Yao, J., Takkar, R., Lee, W.P., Damico-Beyer, L.A., Carano, R.D., Adams, C., Kelley, R.F., Wang, W., Ferrara, N.
Description: Development and Preclinical Characterization of a Humanized Antibody Targeting CXCL12